PT - JOURNAL ARTICLE AU - Hearne, Luke J. AU - Yeo, B.T. Thomas AU - Webb, Lachlan AU - Zalesky, Andrew AU - Fitzgerald, Paul B. AU - Murphy, Oscar W. AU - Tian, Ye AU - Breakspear, Michael AU - Hall, Caitlin V. AU - Choi, Sunah AU - Kim, Minah AU - Kwon, Jun Soo AU - Cocchi, Luca TI - Distinct cognitive and functional connectivity features from healthy cohorts inform clinical obsessive-compulsive disorder AID - 10.1101/2024.09.02.24312960 DP - 2024 Jan 01 TA - medRxiv PG - 2024.09.02.24312960 4099 - http://medrxiv.org/content/early/2024/09/04/2024.09.02.24312960.short 4100 - http://medrxiv.org/content/early/2024/09/04/2024.09.02.24312960.full AB - Improving diagnostic accuracy of obsessive-compulsive disorder (OCD) using models of brain imaging data is a key goal of the field, but this objective is challenging due to the limited size and phenotypic depth of clinical datasets. Leveraging the phenotypic diversity in large non-clinical datasets such as the UK Biobank (UKBB), offers a potential solution to this problem. Nevertheless, it remains unclear whether classification models trained on non-clinical populations will generalise to individuals with clinical OCD. This question is also relevant for the conceptualisation of OCD; specifically, whether the symptomology of OCD exists on a continuum from normal to pathological. Here, we examined a recently published “meta-matching” model trained on functional connectivity data from five large normative datasets (N=45,507) to predict cognitive, health and demographic variables. Specifically, we tested whether this model could classify OCD status in three independent clinical datasets (N=345). We found that the model could identify out-of-sample OCD individuals. Notably, the most predictive functional connectivity features mapped onto known cortico-striatal abnormalities in OCD and correlated with genetic brain expression maps previously implicated in OCD. Further, the meta-matching model relied upon estimates of disordered cognition, such as cognitive flexibility and inhibition, to predict OCD successfully. Overall, our findings suggest that core subclinical features associated with obsessive-compulsive variability can discriminate clinical OCD status. These results support a dimensional and transdiagnostic conceptualisation of the brain and behavioural basis of OCD, with implications for research approaches and treatment targets.Competing Interest StatementL.C., L.J.H, and A.Z. are involved in a not-for-profit clinical neuromodulation centre (Qld. Neurostimulation Centre) that offers neuroimaging-guided neurotherapeutics. In the last 3 years PBF has received equipment for research from Neurosoft and Nexstim. He has served on a scientific advisory board for Magstim and received speaker fees from Otsuka. He has also acted as a founder and board member for TMS Clinics Australia and Resonance Therapeutics.Funding StatementThis work was supported by the Australian NHMRC (GN2001283 and GNT2027597, L.C). A.Z. and L.J.H were supported by research fellowships from the NHMRC (APP1118153, APP1194070, respectively). PBF is supported by a National Health and Medical Research Council of Australia Investigator grant (1193596). BTTY is supported by the NUS Yong Loo Lin School of Medicine (NUHSRO/2020/124/TMR/LOA), the Singapore National Medical Research Council (NMRC) LCG (OFLCG19May-0035), NMRC CTG-IIT (CTGIIT23jan-0001), NMRC STaR (STaR20nov-0003), Singapore Ministry of Health (MOH) Centre Grant (CG21APR1009), the Temasek Foundation (TF2223-IMH-01), and the United States National Institutes of Health (R01MH120080 & R01MH133334).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Human Research Ethics Committee of QIMR Berghofer. Written informed consent was obtained from all participants. All procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesCode used to generate the results will be uploaded to GitHub upon publication. The version of the meta-matching model used in the current work is available online (V2.0; https://github.com/ThomasYeoLab/Meta_matching_models). De-identified participant data for research purposes are available on request for data collected at the Brisbane and Melbourne sites. De-identified participant data for research purposes are available on request for data collected at the Seoul site from the original authors.